Month: May 2025
Pharmaceutical
Sci&Tech
Formulation Methods for Poorly Soluble Drugs
In the development of innovative drugs, poorly soluble candidate drugs of BCSII and BCSIV account for nearly 90%. And statistics show that about 40% of currently marketed drugs are poorly soluble compounds. Due to the poor oral absorption...
Pharmaceutical
Regulation
Sci&Tech
Implement New Approach Methodologies (NAMs) in Drug Development
The landscape of drug development is evolving, with a growing emphasis on reducing and replacing animal testing. New Approach Methodologies (NAMs) are at the forefront of this shift, offering innovative, non-animal methods to assess drug safety...
Pharmaceutical
Regulation
What are drugs made in the US
There’s no strict legal definition of “Made in USA” for drugs enforced by the FDA. However, we can still refer to some regulation requirements to help understand how they are generally categorized in relation to their origin: 1....